UPenn Perelman School of Medicine: Gene Editing Restores Some Sight in Pair of Children Treated for Blindness
May 07, 2024
May 07, 2024
PHILADELPHIA, Pennsylvania, May 7 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release on May 6, 2024:
CRISPR-Cas9 gene editing was found to be safe and largely effective in addressing a form of inherited blindness in a group of patients that, for the first time, included children. In a multi-site clinical trial called BRILLIANCE that included researchers from the Perelman School of Medicine at the University of Pennsylvania . . .
CRISPR-Cas9 gene editing was found to be safe and largely effective in addressing a form of inherited blindness in a group of patients that, for the first time, included children. In a multi-site clinical trial called BRILLIANCE that included researchers from the Perelman School of Medicine at the University of Pennsylvania . . .